Company Filing History:
1 out of 1 
1 out of 1 
1 out of 1 Years Active: 2015-2021
Title: Yiwu Yao: Innovator in Biomedical Research
Introduction
Yiwu Yao is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biomedical research, particularly in the development of novel drug compounds. With a total of 2 patents, his work focuses on addressing critical challenges in immunological therapies and disease treatment.
Latest Patents
Yiwu Yao's latest patents include a heterocyclic urea compound and a drug composition that specifically targets indoleamine-2,3-dioxygenase inhibitors. This invention aims to resolve the issues of weak curative effects and the larger toxic and side effects associated with existing immunological therapy drugs. Additionally, he has developed histone deacetylase (HDAC) inhibitors, which are crucial for treating diseases related to the dysregulation of HDAC. These compounds are synthesized using innovative methods and have applications in pharmaceuticals for preventing or treating various mammal diseases.
Career Highlights
Throughout his career, Yiwu Yao has worked with notable companies such as Nanjing Yoko Biomedical R&D Ltd. and Nanjing Xingang Medical Co., Ltd. His expertise in drug development and biomedical research has positioned him as a key figure in the industry.
Collaborations
Yiwu Yao has collaborated with esteemed colleagues, including Sheng Jiang and Shang Li. Their combined efforts have contributed to advancements in the field of biomedical research.
Conclusion
Yiwu Yao's innovative work in drug development and his contributions to biomedical research highlight his importance as an inventor. His patents reflect a commitment to improving therapeutic options for patients, showcasing the impact of his research on the medical field.